Gabriella Nilsson Hall

Senior Scientist, Cell Therapy Bioprocessing Team • AstraZeneca

Gabriella Nilsson Hall is a Senior Scientist in the Cell Therapy Bioprocessing Team, within the Cell Therapy Department of BioPharmaceuticals R&D at AstraZeneca. Gabriella is responsible for developing and delivering efficient experimental design approaches in support of cell therapy projects while working within an international, highly cross-disciplinary environment with innovative techniques and technologies within areas such as the scalable closed GMP-ready production of pluripotent, immune and tissue-engineered products

Gabriella joined AstraZeneca from Katholieke Universiteit Leuven (KU Leuven) in Belgium where she received her PhD in Biomedical Sciences in 2020. During her doctoral studies, Gabriella cultured human adult stem cells for differentiation towards the mesenchymal lineage and chondrocytes derived from induced pluripotent stem cells (iPSC). Focus was on developing a proof-of-concept of using cartilaginous microtissues as building blocks to generate larger tissues for healing long bone and osteochondral defects. Her work entailed in vitro and in vivo analysis of single microtissues and assemblies. She then continued as a post-doctoral researcher at KU Leuven to pursue process adaptations for future scale-up of microtissue culture and assembly into larger tissues.



Also speaking

Beth Gardner

Senior Director, Patient Supply • Beam Therapeutics

Volker Huppert

Chief Development Officer • GlycoStem

Joshi Venugopal

General Manager, Head of Europe for Gene Therapies and Rare Diseases • Novartis Gene Therapies

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.